Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15004 | 668 | 31.6 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SERTINDOLE | Author keyword | 30 | 42% | 8% | 54 |
| 2 | PSYCHOPHARMACOL VENTURE | Address | 8 | 100% | 1% | 5 |
| 3 | TROP TOXINOL UNIT | Address | 2 | 23% | 1% | 9 |
| 4 | CLIN TOXICOL PHARMACOL | Address | 2 | 13% | 2% | 16 |
| 5 | NEUROLEPTIC AGENT | Author keyword | 2 | 67% | 0% | 2 |
| 6 | QUETIAPINE OVERDOSE | Author keyword | 2 | 67% | 0% | 2 |
| 7 | CITALOPRAM OVERDOSE | Author keyword | 1 | 100% | 0% | 2 |
| 8 | DRUG INDUCED QTC INTERVAL PROLONGATION | Author keyword | 1 | 100% | 0% | 2 |
| 9 | KENT DEV | Address | 1 | 100% | 0% | 2 |
| 10 | TROP TOXICOL UNIT | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SERTINDOLE | 30 | 42% | 8% | 54 | Search SERTINDOLE | Search SERTINDOLE |
| 2 | NEUROLEPTIC AGENT | 2 | 67% | 0% | 2 | Search NEUROLEPTIC+AGENT | Search NEUROLEPTIC+AGENT |
| 3 | QUETIAPINE OVERDOSE | 2 | 67% | 0% | 2 | Search QUETIAPINE+OVERDOSE | Search QUETIAPINE+OVERDOSE |
| 4 | CITALOPRAM OVERDOSE | 1 | 100% | 0% | 2 | Search CITALOPRAM+OVERDOSE | Search CITALOPRAM+OVERDOSE |
| 5 | DRUG INDUCED QTC INTERVAL PROLONGATION | 1 | 100% | 0% | 2 | Search DRUG+INDUCED+QTC+INTERVAL+PROLONGATION | Search DRUG+INDUCED+QTC+INTERVAL+PROLONGATION |
| 6 | ANTIPSYCHOTICS ATYPICAL | 1 | 50% | 0% | 1 | Search ANTIPSYCHOTICS+ATYPICAL | Search ANTIPSYCHOTICS+ATYPICAL |
| 7 | ARRHYTHMOGENIC RISK | 1 | 50% | 0% | 1 | Search ARRHYTHMOGENIC+RISK | Search ARRHYTHMOGENIC+RISK |
| 8 | CD34HEMATOPOIETIC PROGENITOR CELLS | 1 | 50% | 0% | 1 | Search CD34HEMATOPOIETIC+PROGENITOR+CELLS | Search CD34HEMATOPOIETIC+PROGENITOR+CELLS |
| 9 | D LSD | 1 | 50% | 0% | 1 | Search D+LSD | Search D+LSD |
| 10 | DEXMECAMYLAMINE | 1 | 50% | 0% | 1 | Search DEXMECAMYLAMINE | Search DEXMECAMYLAMINE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | OLANZAPINE OVERDOSE | 15 | 82% | 1% | 9 |
| 2 | RISPERIDONE OVERDOSE | 12 | 75% | 1% | 9 |
| 3 | ACUTE PSYCHOTIC PATIENTS | 9 | 83% | 1% | 5 |
| 4 | INTRAVENOUS HALOPERIDOL | 9 | 28% | 4% | 27 |
| 5 | QUETIAPINE OVERDOSE | 6 | 80% | 1% | 4 |
| 6 | ARIPIPRAZOLE EXPOSURES | 6 | 100% | 1% | 4 |
| 7 | CLOZAPINE INTOXICATION | 3 | 100% | 0% | 3 |
| 8 | QUETIAPINE FUMARATE OVERDOSE | 3 | 100% | 0% | 3 |
| 9 | CITALOPRAM OVERDOSE | 3 | 37% | 1% | 7 |
| 10 | PSYCHOTROPIC DRUG THERAPY | 3 | 60% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Citalopram, QTc Prolongation, and Torsades de Pointes | 2015 | 2 | 32 | 69% |
| QTc Prolongation, Torsades de Pointes, and Psychotropic Medications | 2013 | 34 | 74 | 49% |
| QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia | 2010 | 31 | 30 | 73% |
| Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling? | 2012 | 23 | 22 | 64% |
| QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review | 2014 | 6 | 176 | 48% |
| Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics | 2015 | 1 | 51 | 43% |
| QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes | 2011 | 32 | 51 | 45% |
| Atypical antipsychotics - From potassium channels to Torsade de Pointes and sudden death | 2005 | 55 | 77 | 65% |
| Antipsychotic drugs and QT prolongation | 2005 | 75 | 42 | 50% |
| Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death | 2001 | 410 | 40 | 35% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PSYCHOPHARMACOL VENTURE | 8 | 100% | 0.7% | 5 |
| 2 | TROP TOXINOL UNIT | 2 | 23% | 1.3% | 9 |
| 3 | CLIN TOXICOL PHARMACOL | 2 | 13% | 2.4% | 16 |
| 4 | KENT DEV | 1 | 100% | 0.3% | 2 |
| 5 | TROP TOXICOL UNIT | 1 | 40% | 0.3% | 2 |
| 6 | ANESTHESIOL INTENS CARE CLIN PHARMACOL | 1 | 50% | 0.1% | 1 |
| 7 | BIOPOLAR DISORDERS CLIN | 1 | 50% | 0.1% | 1 |
| 8 | COMMUNITY BASED PRACTICE | 1 | 50% | 0.1% | 1 |
| 9 | COURSE MED DENT SCI BIOMED SCI MED | 1 | 50% | 0.1% | 1 |
| 10 | EA NEUROCARDIOL PHYSIOPATHOL TROUBLES RYTHME CARD | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000186590 | TORSADES DE POINTES//TORSADE DE POINTES//ELECT ENGN CYBERNET |
| 2 | 0.0000177311 | 9 HYDROXYRISPERIDONE//NORCLOZAPINE//PALIPERIDONE |
| 3 | 0.0000160020 | ACUTE AGITATION//INHALED LOXAPINE//INTRAMUSCULAR HALOPERIDOL |
| 4 | 0.0000153128 | CYCLIC ANTIDEPRESSANT//AMITRIPTYLINE POISONING//TRICYCLIC ANTIDEPRESSANT POISONING |
| 5 | 0.0000148086 | META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE |
| 6 | 0.0000147917 | QT DISPERSION//QT INTERVAL//THOROUGH QT STUDY |
| 7 | 0.0000131101 | CLOZAPINE//RISPERIDONE//OLANZAPINE |
| 8 | 0.0000113751 | HERG//HUMAN ETHER A GO GO RELATED GENE//HERG CHANNEL |
| 9 | 0.0000110594 | SOUR CHERRY SEED EXTRACT//SOUR CHERRY KERNEL//ANTI PSYCHOTIC DRUG |
| 10 | 0.0000086537 | SEROTONIN SYNDROME//SEROTONIN TOXICITY//COMPLICATIONS SEROTONIN SYNDROME |